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ompA: JF803906). All samples were 
cultured in human embryonic lung 
fibroblasts as described (6). After 4 
weeks, no bacteria were isolated. 
We report a human case of R. es-
chlimannii infection in Crete, Greece. 
Our finding was confirmed by molec-
ular methods. However, we were not 
able to cultivate R. aeschlimannii from 
samples collected. This result suggests 
that living microorganisms may have 
died before testing or that only DNA, 
but no living organism, was present in 
the samples. R. aeschlimannii was first 
isolated from Hyalomma marginatum 
ticks from Morocco (7). In Europe, 
R. aeschlimannii has also been found 
in ticks from Germany, Russia, Italy, 
France, Croatia, Portugal, and Spain 
(8). In Greece, R. aeschlimannii has 
been detected in H. anatolicum exca-
vatum ticks collected from sheep (1). 
The tick removed from this patient 
was Rh. turanicus, a species that has 
been reported in Spain to be infected 
with R. aeschlimannii (9). 
The first human case of R. ae-
schlimannii infection was identified 
in a patient who had fever, rash, and 
an eschar after travel in Morocco 
(10). R. aeschlimannii infections in 
humans have been previously con-
firmed in South Africa, in Algeria, 
and in Tunisia (8). To our knowledge, 
human cases of R. aeschlimannii in-
fection have not been reported in 
Europe. Our results emphasize that 
ticks should be considered as poten-
tial vectors for rickettsial infections 
in humans. We recommend that when 
one species or serotype of tick-trans-
mitted Rickettsia is identified in an 
area, physicians be informed through 
established clinical or public health 
channels of the potential pathogen, 
its manifestations, and recommended 
treatments for humans. 
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Antibodies against 
Rift Valley Fever 
Virus in Cattle,  
Mozambique
To the Editor: During the past 
2 decades, several countries in Africa 
and the Arabian Peninsula, to which 
Rift Valley fever virus (RVFV) is en-
demic, have reported outbreaks of Rift 
Valley fever in humans and livestock. 
The first evidence of RVFV in Mo-
zambique was documented as early as 
the 1960s (1). Endemicity was subse-
quently confirmed in the 1980s by a 
prevalence study that identified virus-
specific antibodies in 2% of pregnant 
women (2) and in the 1990s by sero-
surveillance in Zambezia Province, 
which showed that cattle had been 
infected with RVFV (3).
Apart from those observations, 
the RVFV situation in Mozambique 
is still poorly understood. We recently 
found an unexpectedly high level of 
RVFV activity in cattle in Namaacha 
District in Maputo Province (4), a re-
gion where there had been no recorded 
evidence of the virus since 1969 (1). 
We conducted a cross-sectional study 
in which serum samples were col-
lected throughout Maputo Province 
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during 2010–2011 to ascertain wheth-
er any RVFV circulation had remained 
undetected among bovids.
The study was approved by the 
Mozambican Board of Agriculture. 
Animals investigated were of mixed 
breed, had been present in their re-
spective localities since birth, were >6 
months of age, and had not been vac-
cinated against RVFV. Samples were 
analyzed by using a plaque-reduction 
neutralization test (4), and RVFV se-
ropositivity was defined as 80% re-
duction of virus infectivity at a serum 
dilution of 1:40.
A total of 404 serum samples were 
analyzed, and 149 were positive for 
RVFV-neutralizing antibodies. This 
finding represents an overall serop-
revalence of 36.9% (95% CI 32.2%–
41.6%) in Maputo Province, which is 
a high level for an area in which no 
RVFV disease activity has been re-
ported during the past 4 decades.
Although the study was designed 
to determine the overall prevalence 
in the province, our data also pro-
vided an indication of the distribution 
of RVFV at a district level. Maputo 
Province is subdivided into 7 districts, 
and samples from 6 of these districts 
were available for analysis: Boane (n 
= 28), Magude (n = 34), Manhiça (n 
= 65), Marracuene (n = 82), Matu-
tuine (n = 131), and Moamba (n = 64). 
The livestock populations in Magude, 
Manhiça, Matutuine, and Moamba 
Districts range in size from 20,000 to 
70,000 animals, and Boane and Mar-
racuene Districts have smaller popula-
tions of 6,000 and 9,000, respectively.
We found the highest serop-
revalence to be 61.5% (95% CI 
49.7%–73.4%) in Manhiça District 
and 62.2% (95% CI 51.7%–72.7%) 
in Marracuene District. Some of the 
animals affected by RVFV during out-
breaks in 1969 were raised on farms 
near or in these 2 regions (1). Our 
data indicate that the RVFV activity 
is still high in those districts, possibly 
because breeding of mosquito vectors 
is promoted by environmental factors, 
including irrigation ditches on sugar 
cane farms, extensive flood plains, 
wetlands, and ponds (5).
South Africa keeps continuous 
records of RVFV outbreaks, and sev-
eral outbreaks in cattle were reported 
in KwaZulu-Natal and Mpumalanga 
Provinces during 2008–2010 (6). Ma-
tutuine, the southernmost district in 
Maputo Province, shares a border with 
KwaZulu-Natal Province, whereas 
Magude and Moamba Districts border 
Mpumalanga Province. Accordingly, 
the high seropositivity rates of 19.8% 
(95% CI 13.0%–26.7%), 26.5% (95% 
CI 11.6%–41.3%), and 29.7.% (95% 
CI 18.5%–40.9%) in Matutuine, Ma-
gude, and Moamba Districts, respec-
tively, are not remarkable. In com-
parison, a seroprevalence of 14.3% 
(95% CI 1.3%–27.2%) was noted in 
Boane District, which has a smaller 
livestock population.
Because of long-term persistence 
of IgG against RVFV, the actual time of 
infection could not be determined from 
the data obtained in our study. Howev-
er, information was available regard-
ing the age of the cattle in Moamba 
District. From this information, we 
deduced that the most recent RVFV 
infections in this district occurred at 
some point during 2009–2010.
Our results strongly suggest that 
RVFV is widely distributed among 
bovids in Maputo Province, although 
the modality of this circulation is un-
known. RVFV infection can remain 
undetected in adult livestock but can 
cause abortions in pregnant animals 
and neonatal death in small ruminants 
(7), which has major economic con-
sequences. Transmission to humans 
is common during epizootics, and the 
proximity to and density of cattle in 
an area have been shown to be major 
factors for RVFV seroconversion in 
human populations (8). Human infec-
tions are often manifested as a febrile 
illness and can easily be mistaken for 
other diseases. Consequently, uniden-
tified or underdiagnosed RVFV in-
fections among livestock in Maputo 
Province warrant further research, and 
implementation of surveillance and 
livestock vaccination programs in the 
studied area should be discussed.
Acknowledgment
We thank Z. Massicame and A. Malu-
mana for providing bovine serum samples.
This study was supported by the 
Swedish International Development Co-
operation Agency.
Nina Lagerqvist,  
Belisário Moiane,  
Lourenço Mapaco,  
José Fafetine, Sirkka Vene,  
and Kerstin I. Falk
Author	 affiliations:	 Karolinska	 Institutet,	
Stockholm,	 Sweden	 (N.	 Lagerqvist,	 B.	
Moiane,	 K.I.	 Falk);	 Swedish	 Institute	 for	








  1. Valadão FG. Notes about the occurrence 
of a new disease in Mozambique: Rift 
Valley fever [in Portuguese]. Veterinaria 
Mocambicana. 1969;2:13–20.
  2. Niklasson B, Liljestrand J, Berg-
ström S, Peters CJ. Rift Valley fever: a 
sero-epidemiological survey among preg-
nant women in Mozambique. Epidemiol 
Infect. 1987;99:517–22. http://dx.doi.
org/10.1017/S0950268800068011
  3. Annual report 2001 [in Portuguese]. 
Maputo (Mozambique): National Direc-
torate of Livestock; 2002. p. 32–3.
  4. Lagerqvist N, Moiane B, Bucht G, 
Fafetine J, Paweska JT, Lundkvist A, 
et al. Stability of a formalin-inactivated 
Rift Valley fever vaccine: evaluation of a 
vaccination campaign for cattle in Mozam-
bique. Vaccine. 2012;30:6534–40. http://
dx.doi.org/10.1016/j.vaccine.2012.08.052
  5. Asante K, Brito R, Brundrit G, Epstein 
P, Fernandes A, Marques MR, et al., edi-
tors. Climate change report: study on the 
impact of climate change on disaster risk 
in Mozambique. Maputo (Mozambique); 




  6. World Organization of Animal Health 
(OIE). World animal health information 
database 2008, 2009 and 2010 [cited 2013 
Apr 26]. http://www.oie.int/wahis_2/ 
public/wahid.php/Wahidhome/Home
  7. Ikegami T, Makino S. The pathogenesis 
of Rift Valley fever. Viruses. 2011;3:493–
519. http://dx.doi.org/10.3390/v3050493
  8. Heinrich N, Saathoff E, Weller N, Clowes 
P, Kroidl I, Ntinginya E, et al. High sero-
prevalence of  Rift Valley fever and evi-
dence for endemic circulation in Mbeya 
region, Tanzania, in a cross-sectional 
study.  PLoS Negl Trop Dis. 2012;6:e1557. 
Address for correspondence: Nina Lagerqvist, 
Swedish Institute for Communicable Disease 
Control, Nobelsväg 18, SE-171 82 Solna, 
Sweden; email: nina.lagerqvist@smi.se
Avian Influenza 
A(H7N9) Virus  
Infections,  
Shanghai, China
To the Editor: On March 31, 
2013, the National Health and Family 
Planning Commission of China 
notified the World Health Organization 
of 3 cases of human infections with 
avian influenza A(H7N9) virus. 
These cases were caused by a novel 
virus that was identified by laboratory 
testing at the China Centers for 
Disease Control and Prevention 
(CDC) on March 29 (1).
As of April 19, 2013, a total 
of 91 laboratory-confirmed human 
cases (17 deaths) of infection with 
avian influenza A(H7N9) virus were 
reported in 4 provinces in China 
(2). We report clinical features of 2 
infected adults who died, 2 critically 
ill infected adults who recovered, 
and 1 infected child who had a 
mild case during this outbreak in 
Shanghai, China.
A 3.5-year-old boy had fever 
(39.5°C) for 3 days and mild rhinorrhea 
starting on March 31. He was admitted 
to a district pediatric outpatient clinic 
on April 1. At admission, the child 
was given oseltamivir for 5 days, 
even though signs and symptoms 
had resolved. Nasopharyngeal swab 
samples were positive by real-time PCR 
for avian influenza A(H7N9) virus. All 
symptoms resolved uneventfully by 
April 3, and CDC was notified that 
avian influenza A(H7N9) virus was 
identified in his respiratory sample. 
The patient was discharged on day 11 
after illness onset.
The 4 adult patients were given 
diagnoses of severe pneumonia with 
shortness of breath, dyspnea, and 
marked hypoxia (Table). Duration from 
disease onset to severe illness was 5–7 
days. At admission, the 4 patients with 
severe cases had decreased peripheral 
blood leukocyte counts and increased 
levels of aspartate aminotransferase; 
3 had increased levels of lactate 
dehydrogenase (Table).
All 4 adult patients had 
radiologically confirmed pneumonia 
and bilateral patchy alveolar opacities 
or diffused lobar consolidation with 
or without pleural effusion (Figure, 
Appendix, wwwnc.cdc.gov/EID/article 
/19/7/13-0523-F1.htm). Findings on 
chest radiographs for severe cases 
requiring mechanical ventilation 
were consistent with those for acute 
respiratory distress syndrome.
Among the 4 severe cases in 
adults, a 52-year-old woman (patient 
1) and a 49-year-old man (patient 2) 
died from acute respiratory distress 
syndrome and multiple organ failure 
on days 14 and 10, respectively, 
after disease onset and 1–2 days 
after progression to respiratory 
failure. Two other patients showed 
improvement and were virus negative 
6 and 4 days after antiviral treatment. 
After 23–24 days of treatment in an 
intensive care unit, the 2 patients 
with severe cases recovered and were 
discharged (Table).
The 2 patients who died were 
given methylprednisolone. Of the 2 
patients who recovered, 1 was given 
a low dose of methylprednisolone 
for 1 week and the other was not 
given methylprednisolone. Although 
it is difficult to assess the role of 
glucocorticoids in treatment because 
of limited number of cases, caution 
is advised because of possible serious 
adverse events, including death, as 
reported for human infection with 
influenza A(H1N1) virus (4).
One of the adult patients reported 
exposure to poultry. The family of 
the child patient raised chickens 
and ducks, but these animals had no 
apparent disease, and cloacal swab 
specimens were negative for avian 
influenza A(H7N9) virus. One patient 
who died (patient 2) had frequent 
occupational exposure to poultry. 
Sixteen contacts of the child and 45 
contacts of the 4 adult patients were 
monitored, and routine virologic 
sampling was performed. One contact 
(husband of patient 1) of a patient who 
died (Table) became febrile and was 
positive for avian influenza A(H7N9) 
virus on April 12 (day 24 after disease 
onset for patient 1); as of the date of 
this report, he was receiving treatment 
in an intensive care unit. However, 
it is difficult to tell if this is a case 
of human-to-human transmission 
or if both persons were exposed to 
infectious poultry. All remaining 
contacts had no symptoms and were 
negative for virus by PCR.
Several features of this avian 
influenza A(H7N9) outbreak are 
distinct from those of previous avian 
influenza outbreaks. Human infection 
with this virus showed a case-fatality 
rate of 18.7% (17/91), but this rate 
is not as high as that for avian 
influenza A(H5N1) virus (case-fatality 
rate 59%) (5).
Avian influenza A(H7N9) virus 
infection seems to cause more severe 
human illness than do other subgroups 
of H7 influenza A viruses (subtypes 
H7N2, H7N3, and H7N7), which 
are usually associated with poultry 
outbreaks but cause mild disease in 
humans. However, infection with avian 
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